RENFLEXIS
RENFLEXIS
Approved
DIN Number
02470373
Drug Class
Human
Market Date
Mar 22, 2018
Company
HC
Samsung Bioepis Co., Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02470373
AIG Number0144162001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AB02 INFLIXIMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:24.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
INFLIXIMABActive
Strength: 100 MG / VIAL
Monograph: INFLIXIMAB